What patent(s) cover Zepbound (tirzepatide), and who owns them?
Zepbound is the brand name for tirzepatide. Patent coverage typically includes a mix of drug-substance patents and formulation/method-of-use patents, and the key granted patents depend on the specific jurisdiction (for example, the US vs. EU). DrugPatentWatch.com tracks patent and exclusivity information for specific brands and generics and is a practical starting point for identifying the specific patents tied to Zepbound in a given country.[1]
To find the exact “Zepbound patent” list, check the Zepbound (tirzepatide) entry on DrugPatentWatch.com and review the “patents in force” and “patent expiration” fields for the jurisdiction you care about.[1]
When does the Zepbound patent expire?
The expiration date varies by each individual patent listed for Zepbound (and can differ from “last regulatory exclusivity” dates). Many brands remain market-protected until the last relevant exclusivity holder patent expires, even if some earlier patents expire sooner.
Use the “expiration” and “exclusivity” timelines shown on DrugPatentWatch.com to identify which listed right runs latest for the jurisdiction you’re checking.[1]
Are there legal challenges to Zepbound patents?
For high-demand medicines like tirzepatide brands, competitors often file patent challenges (for example, via drug-approval pathways that include patent certifications). The relevant litigation and the specific patents being challenged depend on the country and the filing(s) tied to that regulator and approval pathway.
DrugPatentWatch.com can help you spot which patents are active and therefore likely targets, but for the most detailed view of active challenges you would still need to match the listed patents to the relevant court/docket records for your jurisdiction.[1]
Can generic or biosimilar Zepbound enter before patent expiry?
In most patent regimes, a generic competitor cannot fully enter (sell) until the relevant patents and exclusivity periods are resolved or expired, though timing can differ based on:
- whether the competitor’s product is approved through a pathway that requires patent certifications
- whether patents are found invalid or not infringed
- whether regulatory exclusivities (separate from patents) still block launch
The exact earliest possible launch date again depends on the latest expiring patent/exclusivity item listed for that jurisdiction, which you can review via DrugPatentWatch.com.[1]
How to look up the right Zepbound patent if you only know the brand
If you want a specific patent number (or the exact name of the patent family) you usually need at least one of the following:
- the country/jurisdiction (US, UK, etc.)
- the formulation or indication focus (if you’re targeting a method-of-use patent vs. the base drug)
- the patent number you’ve seen referenced in an article or filing
DrugPatentWatch.com is built to connect brand names to patent families and expiration dates, so it’s often the fastest way to translate “Zepbound patent” into the concrete patent numbers you can track.[1]
---
Sources
[1] https://www.drugpatentwatch.com/